Top of this page
Skip navigation, go straight to the content

The second Monday of February is International #EpilepsyDay where people come together to highlight problems faced by the 65 million people living with #epilepsy worldwide. Yet despite the high prevalence, many patients will not receive treatment https://
— UCB News (@ucb_news) 05.02.2020
UCB scientists have discovered the first ‘small molecules’ that could inhibit TNF – a key protein involved in inflammatory diseases, including rheumatoid arthritis https://t.co/XPRsE9VZQH https://t.co/KPwbVJE30m
— UCB News (@ucb_news) 04.02.2020
Check out the new Data Transparency Policy section on our website https://t.co/domDHkdHMP #RWE #RWD #BigData #transparency https://t.co/GBqx1OO3xr
— UCB News (@ucb_news) 03.02.2020

At UCB, we take our responsibility
to the planet very seriously.

UCB Ventures, our strategic corporate venture fund established in 2017

Dear User,
Some of the functionalities available on UCB's internet website www.ucb.com might not work properly with Internet Explorer.
For a better user experience, we advise you to access the website with one of the following browsers: